Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 42.95
0.00 (0.00%)
At close: Mar 6, 2026
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.47 billion as of March 6, 2026. Its market cap has decreased by -23.64% in one year.
Market Cap
3.47B
Enterprise Value
2.73B
Revenue
792.49M
Ranking
n/a
PE Ratio
16.58
Stock Price
42.95
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has decreased from 3.53B to 3.47B, a decrease of -1.69%. That is a compound annual growth rate of -0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.47B | 0.35% |
| Dec 31, 2025 | 3.45B | -20.87% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 7.75B |
| Formosa Optical Technology | 5.93B |
| Pacific Hospital Supply | 5.91B |
| St.Shine Optical | 5.55B |
| SciVision Biotech | 5.08B |
| Bionime | 3.80B |
| Nang Kuang Pharmaceutical | 3.74B |
| ICARES Medicus | 3.28B |